Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Assets Average (2016 - 2025)

Historic Assets Average for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to $1.6 billion.

  • Amphastar Pharmaceuticals' Assets Average rose 806.32% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 806.32%. This contributed to the annual value of $1.5 billion for FY2024, which is 3705.19% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Assets Average stood at $1.6 billion for Q3 2025, which was up 806.32% from $1.6 billion recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Assets Average high stood at $1.6 billion for Q3 2025, and its period low was $638.5 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $1.1 billion (2023), whereas its average is $1.1 billion.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Assets Average soared by 10818.29% in 2023, and later surged by 212.93% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Assets Average (Quarter) stood at $661.6 million in 2021, then increased by 10.99% to $734.3 million in 2022, then surged by 108.18% to $1.5 billion in 2023, then grew by 2.13% to $1.6 billion in 2024, then increased by 5.09% to $1.6 billion in 2025.
  • Its Assets Average was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.6 billion in Q1 2025.